Cargando…

Circulating tumor DNA shows variable clonal response of breast cancer during neoadjuvant chemotherapy

Circulating tumor DNA (ctDNA) correlates with tumor burden and provides early detection of treatment response and tumor genetic alterations in breast cancer (BC). In this study, we aimed to identify genetic alterations during the process of tumor clonal evolution and examine if ctDNA level well indi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ji-Yeon, Park, Donghyun, Son, Dae-Soon, Nam, Seok Jin, Kim, Seok Won, Jung, Hae Hyun, Kim, Yeon Jeong, Park, Gahee, Park, Woong-Yang, Lee, Jeong Eon, Park, Yeon Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689695/
https://www.ncbi.nlm.nih.gov/pubmed/29156805
http://dx.doi.org/10.18632/oncotarget.21198